Cargando…

Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography

Background: Radiopaque breast markers cause artifacts in dedicated spiral breast-computed tomography (SBCT). This study investigates the extent of artifacts in different marker types and the feasibility of reducing artifacts through a metal artifact reduction (MAR) algorithm. Methods: The pilot stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Wetzl, Matthias, Wenkel, Evelyn, Steiding, Chrisitan, Ruth, Veikko, Emons, Julius, Wasser, Martin N., Uder, Michael, Ohlmeyer, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572310/
https://www.ncbi.nlm.nih.gov/pubmed/37835805
http://dx.doi.org/10.3390/diagnostics13193062
_version_ 1785120205077217280
author Wetzl, Matthias
Wenkel, Evelyn
Steiding, Chrisitan
Ruth, Veikko
Emons, Julius
Wasser, Martin N.
Uder, Michael
Ohlmeyer, Sabine
author_facet Wetzl, Matthias
Wenkel, Evelyn
Steiding, Chrisitan
Ruth, Veikko
Emons, Julius
Wasser, Martin N.
Uder, Michael
Ohlmeyer, Sabine
author_sort Wetzl, Matthias
collection PubMed
description Background: Radiopaque breast markers cause artifacts in dedicated spiral breast-computed tomography (SBCT). This study investigates the extent of artifacts in different marker types and the feasibility of reducing artifacts through a metal artifact reduction (MAR) algorithm. Methods: The pilot study included 18 women who underwent contrast-enhanced SBCT. In total, 20 markers of 4 different types were analyzed for artifacts. The extent of artifacts with and without MAR was measured via the consensus of two readers. Image noise was quantitatively evaluated, and the effect of MAR on the detectability of breast lesions was evaluated on a 3-point Likert scale. Results: Breast markers caused significant artifacts that impaired image quality and the detectability of lesions. MAR decreased artifact size in all analyzed cases, even in cases with multiple markers in a single slice. The median length of in-plain artifacts significantly decreased from 31 mm (range 11–51 mm) in uncorrected to 2 mm (range 1–5 mm) in corrected images (p ≤ 0.05). Artifact size was dependent on marker size. Image noise in slices affected by artifacts was significantly lower in corrected (13.6 ± 2.2 HU) than in uncorrected images (19.2 ± 6.8 HU, p ≤ 0.05). MAR improved the detectability of lesions affected by artifacts in 5 out of 11 cases. Conclusion: MAR is feasible in SBCT and improves the image quality and detectability of lesions.
format Online
Article
Text
id pubmed-10572310
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105723102023-10-14 Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography Wetzl, Matthias Wenkel, Evelyn Steiding, Chrisitan Ruth, Veikko Emons, Julius Wasser, Martin N. Uder, Michael Ohlmeyer, Sabine Diagnostics (Basel) Article Background: Radiopaque breast markers cause artifacts in dedicated spiral breast-computed tomography (SBCT). This study investigates the extent of artifacts in different marker types and the feasibility of reducing artifacts through a metal artifact reduction (MAR) algorithm. Methods: The pilot study included 18 women who underwent contrast-enhanced SBCT. In total, 20 markers of 4 different types were analyzed for artifacts. The extent of artifacts with and without MAR was measured via the consensus of two readers. Image noise was quantitatively evaluated, and the effect of MAR on the detectability of breast lesions was evaluated on a 3-point Likert scale. Results: Breast markers caused significant artifacts that impaired image quality and the detectability of lesions. MAR decreased artifact size in all analyzed cases, even in cases with multiple markers in a single slice. The median length of in-plain artifacts significantly decreased from 31 mm (range 11–51 mm) in uncorrected to 2 mm (range 1–5 mm) in corrected images (p ≤ 0.05). Artifact size was dependent on marker size. Image noise in slices affected by artifacts was significantly lower in corrected (13.6 ± 2.2 HU) than in uncorrected images (19.2 ± 6.8 HU, p ≤ 0.05). MAR improved the detectability of lesions affected by artifacts in 5 out of 11 cases. Conclusion: MAR is feasible in SBCT and improves the image quality and detectability of lesions. MDPI 2023-09-26 /pmc/articles/PMC10572310/ /pubmed/37835805 http://dx.doi.org/10.3390/diagnostics13193062 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wetzl, Matthias
Wenkel, Evelyn
Steiding, Chrisitan
Ruth, Veikko
Emons, Julius
Wasser, Martin N.
Uder, Michael
Ohlmeyer, Sabine
Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography
title Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography
title_full Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography
title_fullStr Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography
title_full_unstemmed Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography
title_short Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography
title_sort feasibility of in vivo metal artifact reduction in contrast-enhanced dedicated spiral breast computed tomography
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572310/
https://www.ncbi.nlm.nih.gov/pubmed/37835805
http://dx.doi.org/10.3390/diagnostics13193062
work_keys_str_mv AT wetzlmatthias feasibilityofinvivometalartifactreductionincontrastenhanceddedicatedspiralbreastcomputedtomography
AT wenkelevelyn feasibilityofinvivometalartifactreductionincontrastenhanceddedicatedspiralbreastcomputedtomography
AT steidingchrisitan feasibilityofinvivometalartifactreductionincontrastenhanceddedicatedspiralbreastcomputedtomography
AT ruthveikko feasibilityofinvivometalartifactreductionincontrastenhanceddedicatedspiralbreastcomputedtomography
AT emonsjulius feasibilityofinvivometalartifactreductionincontrastenhanceddedicatedspiralbreastcomputedtomography
AT wassermartinn feasibilityofinvivometalartifactreductionincontrastenhanceddedicatedspiralbreastcomputedtomography
AT udermichael feasibilityofinvivometalartifactreductionincontrastenhanceddedicatedspiralbreastcomputedtomography
AT ohlmeyersabine feasibilityofinvivometalartifactreductionincontrastenhanceddedicatedspiralbreastcomputedtomography